Encompass Health Corporation
EHC · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $599,400 | $361,600 | $365,900 | $517,600 |
| Dep. & Amort. | $299,600 | $273,900 | $243,600 | $219,600 |
| Deferred Tax | $10,700 | $3,900 | $27,900 | $17,400 |
| Stock-Based Comp. | $48,300 | $50,600 | $29,200 | $29,100 |
| Change in WC | $21,900 | $50,300 | -$30,400 | -$118,000 |
| Other Non-Cash | $22,900 | $110,500 | $69,600 | $50,100 |
| Operating Cash Flow | $1,002,800 | $850,800 | $705,800 | $715,800 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$642,500 | -$583,100 | -$584,100 | -$551,200 |
| Net Acquisitions | $0 | $0 | $64,100 | -$118,600 |
| Inv. Purchases | -$22,500 | -$23,000 | -$35,200 | -$9,000 |
| Inv. Sales/Matur. | $18,900 | $0 | -$64,100 | $9,000 |
| Other Inv. Act. | -$7,200 | $3,300 | -$7,700 | $3,500 |
| Investing Cash Flow | -$653,300 | -$602,800 | -$627,000 | -$666,300 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$242,000 | -$83,300 | -$498,200 | -$59,100 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$31,100 | -$8,200 | -$7,300 | -$14,600 |
| Dividends Paid | -$62,800 | -$60,400 | -$99,000 | -$112,200 |
| Other Fin. Act. | $5,300 | -$45,300 | $458,800 | -$54,200 |
| Financing Cash Flow | -$330,600 | -$197,200 | -$145,700 | -$240,100 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $18,900 | $50,800 | -$66,900 | -$190,600 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $104,200 | $53,400 | $120,300 | $310,900 |
| End Cash | $123,100 | $104,200 | $53,400 | $120,300 |
| Free Cash Flow | $360,300 | $267,700 | $121,700 | $164,600 |